Picture of Biohit Oyj logo

BIOBV — Biohit Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Biohit: Acetium lozenge - a promising novel method to assist smoking cessation

Nov 4 (Reuters) - Biohit Oyj  BIOBV.HE : 
    * Smoking intervention study of Biohit Oyj of nearly two 
years of duration using Acetium lozenge has been completed 
    * Says Acetium lozenge is considered to be a promising novel 
intervention method to assist in smoking cessation 
    * In intervention group, 42.9 percent could stop smoking as 
compared to 31.1 percent in placebo group (i.e. Acetium was 37.9 
percent more effective) 
    * Compared to placebo, likelihood of smoking cessation among 
acetium users during trial was up to1.65-fold (i.e., 65 percent 
higher probability) 
 
Source text for Eikon:  ID:nHSU638z  
     
Further company coverage:  BIOBV.HE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48586983920;))

Recent news on Biohit Oyj

See all news